» Articles » PMID: 17574983

Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-phase (99m)Tc-sestamibi Parathyroid Scintigraphy

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2007 Jun 19
PMID 17574983
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Various methodologies for (99m)Tc-sestamibi parathyroid scintigraphy are in clinical use. There are few direct comparisons between the different methods and even less evidence supporting the superiority of one over another. Some reports suggest that SPECT is superior to planar imaging. The addition of CT to SPECT may further improve parathyroid adenoma localization. The purpose of our investigation was to compare hybrid SPECT/CT, SPECT, and planar imaging and to determine whether dual-phase imaging is advantageous for the 3 methodologies.

Methods: Scintigraphy was performed on 110 patients with primary hyperparathyroidism and no prior neck surgery. Of these, 98 had single adenomas and are the subject of this review. Planar imaging and SPECT/CT were performed at 15 min and 2 h after injection. Six image sets (early and delayed planar imaging, SPECT, and SPECT/CT) and combinations of the 2 image sets were reviewed for adenoma localization at 13 possible sites. Each review was scored for location and certainty of focus by 2 reviewer groups. Surgical location served as the standard. Sensitivity, specificity, area under the curve, positive predictive value, negative predictive value, and kappa-values were determined for each method.

Results: The overall kappa-coefficient (certainty of adenoma focus) between reading groups was 0.68 (95% confidence interval, 0.66-0.70). The highest values were for dual-phase studies that included SPECT/CT. Dual-phase planar imaging, SPECT, and SPECT/CT were statistically significantly superior to single-phase early or delayed imaging in sensitivity, area under the curve, and positive predictive value. Neither single-phase nor dual-phase SPECT was statistically superior to dual-phase planar imaging. Early-phase SPECT/CT in combination with any delayed imaging method was superior to dual-phase planar imaging or SPECT for sensitivity, area under the curve, and positive predictive value.

Conclusion: Early SPECT/CT in combination with any delayed imaging method was statistically significantly superior to any single- or dual-phase planar or SPECT study for parathyroid adenoma localization. Localization with dual-phase acquisition was more accurate than with single-phase (99m)Tc-sestamibi scintigraphy for planar imaging, SPECT, and SPECT/CT.

Citing Articles

PARATHYROID CANCER: REVIEW OF UNCOMMON DISEASE.

Yabanoglu H, Arer I, Ozarslan F Acta Endocrinol (Buchar). 2025; 20(2):212-221.

PMID: 39845763 PMC: 11750233. DOI: 10.4183/aeb.2024.212.


Up-to-Date Imaging for Parathyroid Tumor Localization in MEN1 Patients with Primary Hyperparathyroidism: When and Which Ones (A Narrative Pictorial Review).

Berti V, Mungai F, Lucibello P, Brandi M, Biagini C, Imperiale A Diagnostics (Basel). 2025; 15(1.

PMID: 39795539 PMC: 11719470. DOI: 10.3390/diagnostics15010011.


Quantitative application of dual-phase 99mTc-sestamibi SPECT/CT imaging of parathyroid lesions: identification of optimal timing in secondary hyperparathyroidism.

Wang Y, Liu Y, Li N, Xu K, Zhang W EJNMMI Phys. 2023; 10(1):29.

PMID: 37079194 PMC: 10119365. DOI: 10.1186/s40658-023-00548-5.


SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.

Luo X, Zhang Z, Cheng C, Wang T, Fang D, Zuo C Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986521 PMC: 10051245. DOI: 10.3390/ph16030423.


Molecular Imaging Diagnosis of Renal Cancer Using Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques.

Tataru O, Marchioni M, Crocetto F, Barone B, Lucarelli G, Del Giudice F Diagnostics (Basel). 2023; 13(4).

PMID: 36832081 PMC: 9954934. DOI: 10.3390/diagnostics13040593.